跳至主要内容
临床试验/NCT02154464
NCT02154464Unknown不适用

Morphine-sparing Effect of Intravenous Paracetamol for Post-operative Pain Management Following Laparoscopic Gastric Banding in Morbidly Obese Patients

Soroka University Medical Center1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2014年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
220
试验地点
1
主要终点
amount of morphine

研究概览

简要总结

The investigators predict that giving patients paracetamol in the operative period will reduce their need for opioid pain reducers in the post operative setting.

详细描述

This study is designed as a population-based prospective, double blind cohort study. A prospective cohort of patients admitted to laparoscopic gastric banding due to morbid obesity

STUDY GOALS

  • To evaluate the morphine-sparing effect of paracetamol IV in obese patients undergoing bariatric surgery.
  • To identify potential ability of paracetamol IV to attenuate or relief postoperative pain in obesity patient undergoing bariatric surgery
  • To determine effectiveness of paracetamol IV to reduce postoperative complication rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Patients admitted for laparoscopic gastric banding
  • Elective surgery
  • BMI > 40
  • ASA (American Society Anesthesiologists perioperative risk stratification) class 1-2

排除标准

  • Patients' refusal to participate in the study
  • Patients unable to give an informed consent
  • Pregnancy
  • Emergent surgery
  • Patient with known allergy to morphine or paracetamol
  • Patient with hepatic failure (based on history or elevated liver enzymes).
  • ASA class >2.

研究组 & 干预措施

Paracetamol

Active Comparator

干预措施: Paracetamol (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

amount of morphine

时间窗: Until discharge (participants will be followed for the duration of hospital stay, an expected average of 3 days)

The primary outcome will be the comparison amount of morphine injected in each group until discharge

次要结局

  • Length of hospitalization(Until discharge from hospital (participants will be followed for the duration of hospital stay, an expected average of 3 days))
  • Complications during hospitalization.(Until discharge from hospital (participants will be followed for the duration of hospital stay, an expected average of 3 days))
  • Complication during treatment of patient in PACU:(Until discarge from PACU (participants will be followed for the duration of PACU stay, an expected average of 2 hours))
  • Time discharging from PACU(Until discharge from PACU (participants will be followed for the duration of PACU stay, an expected average of 2 hours))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexander Zlotnik

Professor

Soroka University Medical Center

研究点 (1)

Loading locations...

相似试验